64 related articles for article (PubMed ID: 15491322)
1. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.
Li Q; Murphy M; Ross J; Sheehan C; Carlson JA
J Cutan Pathol; 2004 Nov; 31(10):633-42. PubMed ID: 15491322
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer.
Davidovich S; Ben-Izhak O; Shapira M; Futerman B; Hershko DD
Breast Cancer Res; 2008; 10(4):R63. PubMed ID: 18644126
[TBL] [Abstract][Full Text] [Related]
3. SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study.
Laga AC; Zhan Q; Weishaupt C; Ma J; Frank MH; Murphy GF
Exp Dermatol; 2011 Apr; 20(4):339-45. PubMed ID: 21410764
[TBL] [Abstract][Full Text] [Related]
4. Eosinophils in metastatic melanoma.
Proffer SL; Guo R; Demer AM; Peters MS
Hum Pathol; 2023 Nov; 141():110-117. PubMed ID: 37574050
[TBL] [Abstract][Full Text] [Related]
5. CDH22 expression is reduced in metastatic melanoma.
Piche B; Khosravi S; Martinka M; Ho V; Li G
Am J Cancer Res; 2011; 1(2):233-239. PubMed ID: 21969168
[TBL] [Abstract][Full Text] [Related]
6. p27kip1: a target for tumor therapies?
Nickeleit I; Zender S; Kossatz U; Malek NP
Cell Div; 2007 May; 2():13. PubMed ID: 17488529
[TBL] [Abstract][Full Text] [Related]
7. Reduced
Neudorf NM; Thompson LL; Lichtensztejn Z; Razi T; McManus KJ
Cells; 2022 Nov; 11(23):. PubMed ID: 36496990
[TBL] [Abstract][Full Text] [Related]
8. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
Gupta P; Zhao H; Hoang B; Schwartz EL
Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
[TBL] [Abstract][Full Text] [Related]
9. The SCF Complex Is Essential to Maintain Genome and Chromosome Stability.
Thompson LL; Rutherford KA; Lepage CC; McManus KJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445249
[TBL] [Abstract][Full Text] [Related]
10. Emerging Roles of SKP2 in Cancer Drug Resistance.
Wu T; Gu X; Cui H
Cells; 2021 May; 10(5):. PubMed ID: 34068643
[TBL] [Abstract][Full Text] [Related]
11. An Update on the Role of Ubiquitination in Melanoma Development and Therapies.
Soysouvanh F; Giuliano S; Habel N; El-Hachem N; Pisibon C; Bertolotto C; Ballotti R
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33800394
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Malignant Melanoma: A Review of Early Diagnosis and Management.
Naik PP
World J Oncol; 2021 Feb; 12(1):7-19. PubMed ID: 33738001
[TBL] [Abstract][Full Text] [Related]
13. The Skp2 Pathway: A Critical Target for Cancer Therapy.
Cai Z; Moten A; Peng D; Hsu CC; Pan BS; Manne R; Li HY; Lin HK
Semin Cancer Biol; 2020 Dec; 67(Pt 2):16-33. PubMed ID: 32014608
[TBL] [Abstract][Full Text] [Related]
14. SKP2 targeted inhibition suppresses human uveal melanoma progression by blocking ubiquitylation of p27.
Zhao H; Pan H; Wang H; Chai P; Ge S; Jia R; Fan X
Onco Targets Ther; 2019; 12():4297-4308. PubMed ID: 31213847
[No Abstract] [Full Text] [Related]
15. CKS1 expression in melanocytic nevi and melanoma.
Brożyna AA; Aplin A; Cohen C; Carlson G; Page AJ; Murphy M; Slominski AT; Carlson JA
Oncotarget; 2018 Jan; 9(3):4173-4187. PubMed ID: 29423113
[TBL] [Abstract][Full Text] [Related]
16. PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse.
Autilio C; Paolillo C; Lavieri MM; Pocino K; De Paolis E; Di Stasio E; Marchetti P; Gian Carlo CA; Capoluongo E
Oncotarget; 2017 Oct; 8(49):85479-85491. PubMed ID: 29156734
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination in melanoma pathogenesis and treatment.
Ma J; Guo W; Li C
Cancer Med; 2017 Jun; 6(6):1362-1377. PubMed ID: 28544818
[TBL] [Abstract][Full Text] [Related]
18. PCTAIRE1 regulates p27 stability, apoptosis and tumor growth in malignant melanoma.
Yanagi T; Reed JC; Matsuzawa S
Oncoscience; 2014; 1(10):624-33. PubMed ID: 25593992
[TBL] [Abstract][Full Text] [Related]
19. Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy.
Zhou W; Slingerland JM
Nat Rev Cancer; 2014 Jan; 14(1):26-38. PubMed ID: 24505618
[TBL] [Abstract][Full Text] [Related]
20. Tissue prognostic biomarkers in primary cutaneous melanoma.
Mandalà M; Massi D
Virchows Arch; 2014 Mar; 464(3):265-81. PubMed ID: 24487785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
